Michael Powell's Net Worth
$5.25 Million
Who is Michael Powell?
Michael Powell has an estimated net worth of $5.25 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, COTHERIX INC, Orexigen Therapeutics, Inc., Trius Therapeutics Inc, CORGENTECH INC, HYPERION THERAPEUTICS INC, MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Vera Therapeutics, Inc., Aclaris Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Inozyme Pharma, Inc., KALOBIOS PHARMACEUTICALS INC, Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Checkmate Pharmaceuticals, Inc., Galera Therapeutics, Inc., Bolt Biotherapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., THRESHOLD PHARMACEUTICALS INC, aTYR PHARMA INC, ALIMERA SCIENCES INC, Akouos, Inc., NOVACEA INC, Durata Therapeutics, Inc., Versartis, Inc., SEATTLE GENETICS INC /WA, Anthera Pharmaceuticals Inc, Spark Therapeutics, Inc., and Ocera Therapeutics, Inc..
SEC CIK
Michael Powell's CIK is 0001202793
Past Insider Trading and Trends
2006 was Michael Powell's most active year for acquiring shares with 7 total transactions. Michael Powell's most active month to acquire stocks was the month of May. 2006 was Michael Powell's most active year for disposing of shares, totalling 4 transactions. Michael Powell's most active month to dispose stocks was the month of August. 2016 saw Michael Powell paying a total of $15,080.94 for 34,469 shares, this is the most they've acquired in one year. In 2022 Michael Powell cashed out on 70,030 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.75% | -424.90K |
$7.25 | -$3,080,609.98 | 8.51M |
Mar 29
| |||
Form 4
| -6.05% | -575.10K |
$7.55 | -$4,341,332.61 | 8.94M |
Mar 24 - Mar 25
| |||
Form 4
| -17.37% | -2.00M |
$7.50 | -$15,000,000.00 | 9.51M |
Mar 11
| |||
Form 4
| -5.24% | -637.00K |
$7.26 | -$4,622,857.88 | 11.51M |
Mar 9 - Mar 10
| |||
Form 4
| -2.90% | -363.00K |
$8.13 | -$2,952,787.20 | 12.15M |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COTHERIX INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +372.06% | 1.86M |
—
|
—
| 2.36M |
Oct 20
| |||
Form 4
| +252.10% | 358.43K |
$6.00 | $2,150,556.00 | 500.6K |
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orexigen Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| -55.99% | -825.00K |
$8.26 | -$6,836,281.05 | 648.6K |
Dec 21 - Dec 23
| |||
Form 4
| -18.77% | -456.25K |
$8.63 | -$3,913,570.02 | 1.98M |
Dec 17 - Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| -35.33% | -700.00K |
$6.13 | -$4,293,199.99 | 1.28M |
Mar 17 - Mar 19
| |||
Form 4
| -16.80% | -400.00K |
$9.18 | -$3,670,000.00 | 1.98M |
Sep 10
| |||
Form 4
| -14.38% | -400.00K |
$8.00 | -$3,200,000.00 | 2.38M |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
| -0.03% | -700.00 |
$12.09 | -$8,460.20 | 2.75M |
Aug 29
| |||
Form 4
| -1.10% | -30.80K |
$12.05 | -$371,131.40 | 2.78M |
Aug 27 - Aug 28
| |||
Form 4
| -0.36% | -10.10K |
$12.00 | -$121,212.00 | 2.81M |
Aug 21 - Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 2.82M |
—
|
—
| 2.82M |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trius Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9.3K |
$1.29 | $11,999.58 | 9.3K |
Mar 26
| |||
Form 4
| -5.75% | -6.90K |
$5.59 | -$38,556.59 | 113.1K |
Scheduled
|
Jan 18 - Jan 19
| ||
Form 4
| -17.03% | -24.62K |
$5.44 | -$133,994.69 | 120K |
Scheduled
|
Jan 13 - Jan 17
| ||
Form 4
| -96.00% | -3.47M |
—
|
—
| 144.65K |
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +191.08% | 3.62M |
$4.68 | $8,063,070.10 | 5.51M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CORGENTECH INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
∞
| 3.7M |
$4.05 | $15,000,001.20 | 3.7M |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
∞
| 1 |
$6.86 | $6.86 | 1 |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +4,452.85% | 1.18M |
—
|
—
| 1.2M |
Dec 15 - Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||